GlasxoSmithKline

Researcher looking at a tablet
GSK pays $70M to increase its access to Tempus patient data library
By Jessica Hagen | 03:04 pm | October 19, 2022
The multinational pharma company will now be able to access Tempus' de-identified patient data.